Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MD MSc, Kang Howson-Jan, MD FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Benjamin Hedley, PhD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2019) 134 (Supplement_1): 3438.

https://doi.org/10.1182/blood-2019-128507

Published: 2019

Journal Articles

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Yimin Pearl Wang, BSc, Rohan Kehar, MDMSc,FRCPC, Alla Iansavitchene, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2019) 134 (Supplement_1): 3672.

https://doi.org/10.1182/blood-2019-123870

Published: 2019

Journal Articles

Efficacy and Safety of Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism

Renata Almeida Sa, MSc, BSc, Fatimah Al-Ani, MD MRCP, Alejandro Lazo-Langner, MD MSc, Martha L Louzada, MDMSc

Blood (2019) 134 (Supplement_1): 3675.

https://doi.org/10.1182/blood-2019-121765

Published: 2019

Journal Articles

Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review

Alejandro Garcia-Horton, MDFRCPC, Yashoda Valliere, Alejandro Lazo-Langner, MD MSc

Blood (2019) 134 (Supplement_1): 5425.

https://doi.org/10.1182/blood-2019-126806

Published: 2019

Journal Articles

The Impact of Red Blood Cell Transfusion on Mortality and Treatment Efficacy in Patients Treated with Radiation: A Systematic Review of the Literature

Max Deschner, MD, Sondos Zayed, MD CM, Lakshman Vasanthamohan, MD, Alejandro Lazo-Langner, MD MSc, David Palma, MD MSc, PhD, David D'Souza, MD, Syed Omar Gilani, MD, R. Gabriel Boldt, MLIS, Ziad Solh, MD MSc

Blood (2019) 134 (Supplement_1): 4984.

https://doi.org/10.1182/blood-2019-129219

Published: 2019

Journal Articles

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

Michael J. Kovacs, MD, Marc Rodger, MDMSc, Philip S. Wells, MDMSc,FRCP, Shannon M. Bates, MD MSc, Clive Kearon, MB, PhD, Mark Blostein, MDFRCPC, Alejandro Lazo-Langner, MD MSc, Susan Kahn, MD, Sam Schulman, MD PhD FRCPC, Elham Sabri, MSc, Susan Solymoss, MD, Timothy Ramsay, PhD, Luljeta Pallaveshi, RN, BA, David Anderson, MD

Blood (2018) 132 (Supplement 1): 424.

https://doi.org/10.1182/blood-2018-99-109964

Published: 2018

Journal Articles

Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia

Alejandro Garcia-Horton, MD, Rosanne St. Bernard, MD, Alejandro Lazo-Langner, MD MSc, Anargyros Xenocostas, MD, Joy Mangel, MD FRCPC, Kang Howson-Jan, MD FRCPC, Selay Lam, MDBSc, FRCPC, Cyrus C. Hsia, MDBSc, FRCPC

Blood (2018) 132 (Supplement 1): 5560.

https://doi.org/10.1182/blood-2018-99-120129

Published: 2018

Journal Articles

Quantitative Modeling of Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients Yields Distinct Clinical Phenotypes and Can Identify a State of Disease Predictive of Loss of Response to Azacitidine

Roman M Shapiro, MD, Alejandro Lazo-Langner, MD MSc, Adam R Stinchcombe, PhD

Blood (2018) 132 (Supplement 1): 3104.

https://doi.org/10.1182/blood-2018-99-115611

Published: 2018

Journal Articles

Development of a Clinical Prediction Rule for the Risk of Venous Thromboembolism in Patients with Acute Leukemia

Fatimah Al-Ani, MD MRCP, Yimin Pearl Wang, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2018) 132 (Supplement 1): 2223.

https://doi.org/10.1182/blood-2018-99-117405

Published: 2018

Journal Articles

Distribution of Lymphomas in Mexico: A Descriptive Study

Alejandro Garcia-Horton, MD, Adrian Carballo-Zarate, Lizbeth Palma-Berre, Patricia Ramos-Salazar, Rogelio Sanchez-Verin-Lucio, Jorge Valenzuela-Tamariz, Lourdes Molinar-Horcasitas, Alejanda Zarate-Osorno, Alejandro Lazo-Langner, MD MSc

Blood (2017) 130 (Supplement 1): 2127.

https://doi.org/10.1182/blood.V130.Suppl_1.2127.2127

Published: 2017

Journal Articles

Post-Thrombotic Syndrome and Recurrent Thromboembolism in Patients with Upper Extremity Deep Vein Thrombosis: A Systematic Review and Meta-Analysis of Proportions

Kartiga Thiyagarajah, MD, Leah Ellingwood, MD, Kaitlin Endres, BMSc, Aaron Hegazi, BSc, James Radford, MD, Alla Lansavitchene, BSc, MLIS, Alejandro Lazo-Langner, MD MSc

Blood (2017) 130 (Supplement 1): 4724.

https://doi.org/10.1182/blood.V130.Suppl_1.4724.4724

Published: 2017

Journal Articles

A Simple Tool for the Prediction of Azacytidine Treatment Failure in Patients with Myelodysplastic Syndrome

Roman M Shapiro, MD, Alejandro Lazo-Langner, MD MSc

Blood (2017) 130 (Supplement 1): 1706.

https://doi.org/10.1182/blood.V130.Suppl_1.1706.1706

Published: 2017

Journal Articles

Treatment of Venous Thromboembolism in Acute Leukemia: A Systematic Review

Azin Ahrari, MD BSc, Fatimah Al-Ani, MD MRCP, Yimin Pearl Wang, BSc, Alla Iansavitchene, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2017) 130 (Supplement 1): 1114.

https://doi.org/10.1182/blood.V130.Suppl_1.1114.1114

Published: 2017

Journal Articles

Incidence of Venous Thromboembolism in Acute Leukemia: A Systematic Review and Meta-Analysis

Fatimah Al-Ani, MD MRCP, Azin Ahrari, MD BSc, Yimin Pearl Wang, BSc, Alla Iansavitchene, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2017) 130 (Supplement 1): 5634.

https://doi.org/10.1182/blood.V130.Suppl_1.5634.5634

Published: 2017

Journal Articles

Efficacy and Safety of Direct Oral Anticoagulants: A Systematic Review of Population Based Studies

Fatimah Al-Ani, MD MRCP, Ayman Seyam, MD, Alejandro Lazo-Langner, MD MSc, FRCPC

Blood (2016) 128 (22): 1451.

https://doi.org/10.1182/blood.V128.22.1451.1451

Published: 2016

Journal Articles

Long Term Monitoring of Patients with Positive Lupus Anticoagulant and Antiphospholipid Antibodies. Are All Cases Persistently Positive?

Matthew R. Kovacs, Alejandro Lazo-Langner, MD MSc, FRCPC, Martha L Louzada, MD, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 1452.

https://doi.org/10.1182/blood.V128.22.1452.1452

Published: 2016

Journal Articles

Erythropoiesis-Stimulating Agents in Elderly Patients with Anemia of Unknown Etiology: Treatment Response and Cardiovascular Outcomes

Zachary Gowanlock, BASc, Swetha Sriram, MD, Alison Martin, MD, Anargyros Xenocostas, MD, Alejandro Lazo-Langner, MD MSc, FRCPC

Blood (2016) 128 (22): 1267.

https://doi.org/10.1182/blood.V128.22.1267.1267

Published: 2016

Journal Articles

Comparison of the IPSS and IPSS-R in Predicting Survival and Response of Myelodysplastic Syndrome Patients to 5-Azacitidine

Roman M Shapiro, MD, Alejandro Lazo-Langner, MD MSc, FRCPC

Blood (2016) 128 (22): 5550.

https://doi.org/10.1182/blood.V128.22.5550.5550

Published: 2016

Journal Articles

Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

Matthew R. Kovacs, Alejandro Lazo-Langner, MD MSc, FRCPC, Martha L Louzada, MD, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 5017.

https://doi.org/10.1182/blood.V128.22.5017.5017

Published: 2016

Journal Articles

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

Gwynivere A Davies, MD FRCPC, Alejandro Lazo-Langner, MD MSc, FRCPC, Esteban Gandara, MD MSc, FRCPC, Vicky Tagalakis, MD MSc, Martha L Louzada, MD, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 878.

https://doi.org/10.1182/blood.V128.22.878.878

Published: 2016

NARROW

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Efficacy and Safety of Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism

Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review

The Impact of Red Blood Cell Transfusion on Mortality and Treatment Efficacy in Patients Treated with Radiation: A Systematic Review of the Literature

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia

Quantitative Modeling of Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients Yields Distinct Clinical Phenotypes and Can Identify a State of Disease Predictive of Loss of Response to Azacitidine

Development of a Clinical Prediction Rule for the Risk of Venous Thromboembolism in Patients with Acute Leukemia

Distribution of Lymphomas in Mexico: A Descriptive Study

Post-Thrombotic Syndrome and Recurrent Thromboembolism in Patients with Upper Extremity Deep Vein Thrombosis: A Systematic Review and Meta-Analysis of Proportions

A Simple Tool for the Prediction of Azacytidine Treatment Failure in Patients with Myelodysplastic Syndrome

Treatment of Venous Thromboembolism in Acute Leukemia: A Systematic Review

Incidence of Venous Thromboembolism in Acute Leukemia: A Systematic Review and Meta-Analysis

Efficacy and Safety of Direct Oral Anticoagulants: A Systematic Review of Population Based Studies

Long Term Monitoring of Patients with Positive Lupus Anticoagulant and Antiphospholipid Antibodies. Are All Cases Persistently Positive?

Erythropoiesis-Stimulating Agents in Elderly Patients with Anemia of Unknown Etiology: Treatment Response and Cardiovascular Outcomes

Comparison of the IPSS and IPSS-R in Predicting Survival and Response of Myelodysplastic Syndrome Patients to 5-Azacitidine

Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only